Form 4: Incyte Corp: Baker Bros. Advisors Reports Stock Transactions

Baker Bros. Advisors LP and affiliated entities report transactions involving Incyte Corp common stock and stock options, including grants of restricted stock units and non-qualified stock options.

Summary

• Baker Bros. Advisors LP, along with related entities and individuals (including Julian C. Baker and Felix J. Baker), have filed a Form 4 detailing changes in their beneficial ownership of Incyte Corporation (INCY) common stock and derivative securities.
• The filing reports the grant of 1,642 Restricted Stock Units (RSUs) to Julian C. Baker on June 8, 2026, which vest on June 8, 2027, or the next annual meeting, subject to continued service.
• Additionally, 6,111 non-qualified stock options were granted to Julian C. Baker on June 8, 2026, with a strike price of $100.64, vesting on June 8, 2027, and expiring on June 7, 2036.
• The filing also notes dispositions of common stock totaling 278,773 shares and 281,190 shares, though the specific dates and prices for these dispositions are not detailed in the provided text.
• Baker Bros. Advisors LP acts as the investment adviser to various funds that hold significant portions of these securities, with Julian C. Baker and Felix J. Baker having indirect pecuniary interests.
• Julian C. Baker and Felix J. Baker are identified as directors and 10% owners of Incyte Corp.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it primarily details routine equity grants and dispositions by significant beneficial owners and does not contain new strategic information or financial performance data.

Positives

• Grant of 1,642 Restricted Stock Units (RSUs) to Julian C. Baker, indicating continued equity incentive for key personnel.
• Grant of 6,111 non-qualified stock options to Julian C. Baker, providing potential upside participation.
• Baker Bros. Advisors LP and its affiliates maintain significant beneficial ownership, suggesting continued confidence in Incyte Corp.

Negatives

• Dispositions of common stock totaling 278,773 shares and 281,190 shares, indicating a reduction in direct holdings by some reporting persons.
• The strike price of $100.64 for the granted stock options may indicate a significant hurdle for them to become in-the-money.

Risks

• Vesting of RSUs and stock options is subject to Julian C. Baker's continuous service on the board, posing a risk if service is interrupted.
• The filing does not provide details on the reasons for the disposition of a significant number of shares, which could imply a strategic shift or need for liquidity.

Future Outlook

The future outlook is implied through the granting of RSUs and stock options, which are designed to incentivize continued service and align management's interests with shareholders. The vesting schedules and expiration dates provide a timeline for potential future equity events.

Management Comments

• Julian C. Baker serves on the Board as a representative of 667, L.P. and Baker Brothers Life Sciences, L.P.
• Julian C. Baker and Felix J. Baker may be deemed to have an indirect pecuniary interest in securities held by affiliated funds.
• Baker Bros. Advisors LP has complete and unlimited discretion and authority with respect to the investment and voting power of securities held by the Funds.
• Julian C. Baker, Felix J. Baker, the Adviser GP and the Adviser disclaim beneficial ownership of securities held by the Funds except to the extent of their pecuniary interest therein.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard for significant beneficial owners and insiders, particularly for investment firms like Baker Bros. Advisors that often hold substantial stakes in biotechnology and life sciences companies. The grants of equity awards are typical in this sector to attract and retain talent.

Related Party Transactions

• Grants of RSUs and stock options to Julian C. Baker, a director and managing member of affiliated entities.
• Indirect pecuniary interests of Julian C. Baker and Felix J. Baker in securities held by various funds managed by Baker Bros. Advisors LP.

Stakeholder Impact

• Shareholders: The dispositions of shares may influence market supply, while equity grants to management align incentives.
• Employees: The equity awards signal a commitment to retaining key talent within the organization.
• Management: Julian C. Baker and Felix J. Baker's beneficial ownership and director roles are detailed.

Next Steps

• Vesting of 1,642 RSUs on or before June 8, 2027.
• Vesting of 6,111 stock options on or before June 8, 2027.
• Expiration of 6,111 stock options on June 7, 2036.

Key Dates

Keywords

Incyte Corp, INCY, Form 4, Baker Bros. Advisors, Securities Ownership, Stock Options, Restricted Stock Units, Beneficial Ownership, Director, 10% Owner